As we reviewed the molecular characteristics of the four biomarkers among UTUC tumor origin and IVR specimens, we observed that the co-occurrence of FGFR3 and p53 expression increased during the process of bladder cancer progression. The gene discussed is FGFR3; the disease is urinary bladder cancer.